Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lingyan Li

Showing results (131-140 of 139) with videos related to

Pageof 14
Sort By:
You have reached the last page of results.This site can display upto 139 results.
Nature Communications|May 12, 2018
Regulatory protein SrpA controls phage infection and core cellular processes in Pseudomonas aeruginosaJiajia You, Li Sun, Xiaojing Yang, et al.
Frontiers in Immunology|November 8, 2023
A first-in-human, open-label, dose-escalation and dose-expansion phase I study to evaluate the safety, tolerability, pharmacokinetics/pharmacodynamics, and antitumor activity of QL1604, a humanized anti-PD-1 mAb, in patients with advanced or metastatic solid tumorsZhiyu Huang, Yanjun Xu, Wei Hong, et al.
Plos One|July 19, 2012
Metagenomic insights into the fibrolytic microbiome in yak rumenXin Dai, Yaxin Zhu, Yingfeng Luo, et al.
Infection and Drug Resistance|September 23, 2024
Hematocrit and Albumin Levels at Admission Predict in-Hospital Mortality in Pediatric COVID-19 Omicron Variant PatientsYun Zhu, Lingyan Li, Wenxiao Wang, et al.
Advances in Therapy|September 14, 2024
Efficacy and Safety of Iparomlimab, an Anti-PD-1 Antibody, in Patients with Advanced Solid Tumors: A Phase 1c StudyJianping Xiong, Weiwei Ouyang, Mengxiang Yang, et al.
BMC Pulmonary Medicine|December 20, 2024
Effectiveness of high-intensity inspiratory muscle training, and resistance and aerobic exercise for cardiovascular health in chronic obstructive pulmonary disease (HIRAC-COPD): a randomized controlled trial protocolBin Yu, Wenbin Liu, Yuekong Hu, et al.
Journal of Gynecologic Oncology|April 12, 2024
QL1604 plus paclitaxel-cisplatin/carboplatin in patients with recurrent or metastatic cervical cancer: an open-label, single-arm, phase II trialCheng Fang, Yun Zhou, Yanling Feng, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|January 27, 2024
Iruplinalkib (WX-0593) Versus Crizotinib in ALK TKI-Naive Locally Advanced or Metastatic ALK-Positive NSCLC: Interim Analysis of a Randomized, Open-Label, Phase 3 Study (INSPIRE)Yuankai Shi, Jianhua Chen, Runxiang Yang, et al.
Journal of Hematology & Oncology|November 12, 2024
Iparomlimab (QL1604) in patients with microsatellite instability-high (MSI-H) or mismatch repair-deficient (dMMR) unresectable or metastatic solid tumors: a pivotal, single-arm, multicenter, phase II trialFeng Bi, Jian Dong, Chuan Jin, et al.
Pageof 14

Showing results (131-140 of 139) with videos related to

Sort By:
Pageof 14
You have reached the last page of results.This site can display upto 139 results.
Nature Communications|May 12, 2018
Regulatory protein SrpA controls phage infection and core cellular processes in Pseudomonas aeruginosaJiajia You, Li Sun, Xiaojing Yang, et al.
Frontiers in Immunology|November 8, 2023
A first-in-human, open-label, dose-escalation and dose-expansion phase I study to evaluate the safety, tolerability, pharmacokinetics/pharmacodynamics, and antitumor activity of QL1604, a humanized anti-PD-1 mAb, in patients with advanced or metastatic solid tumorsZhiyu Huang, Yanjun Xu, Wei Hong, et al.
Plos One|July 19, 2012
Metagenomic insights into the fibrolytic microbiome in yak rumenXin Dai, Yaxin Zhu, Yingfeng Luo, et al.
Infection and Drug Resistance|September 23, 2024
Hematocrit and Albumin Levels at Admission Predict in-Hospital Mortality in Pediatric COVID-19 Omicron Variant PatientsYun Zhu, Lingyan Li, Wenxiao Wang, et al.
Advances in Therapy|September 14, 2024
Efficacy and Safety of Iparomlimab, an Anti-PD-1 Antibody, in Patients with Advanced Solid Tumors: A Phase 1c StudyJianping Xiong, Weiwei Ouyang, Mengxiang Yang, et al.
BMC Pulmonary Medicine|December 20, 2024
Effectiveness of high-intensity inspiratory muscle training, and resistance and aerobic exercise for cardiovascular health in chronic obstructive pulmonary disease (HIRAC-COPD): a randomized controlled trial protocolBin Yu, Wenbin Liu, Yuekong Hu, et al.
Journal of Gynecologic Oncology|April 12, 2024
QL1604 plus paclitaxel-cisplatin/carboplatin in patients with recurrent or metastatic cervical cancer: an open-label, single-arm, phase II trialCheng Fang, Yun Zhou, Yanling Feng, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|January 27, 2024
Iruplinalkib (WX-0593) Versus Crizotinib in ALK TKI-Naive Locally Advanced or Metastatic ALK-Positive NSCLC: Interim Analysis of a Randomized, Open-Label, Phase 3 Study (INSPIRE)Yuankai Shi, Jianhua Chen, Runxiang Yang, et al.
Journal of Hematology & Oncology|November 12, 2024
Iparomlimab (QL1604) in patients with microsatellite instability-high (MSI-H) or mismatch repair-deficient (dMMR) unresectable or metastatic solid tumors: a pivotal, single-arm, multicenter, phase II trialFeng Bi, Jian Dong, Chuan Jin, et al.
Pageof 14